Natural Alternatives International (FRA:NA2) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NA2 Natural Alternatives International Inc FRA:NA2
48 GF Score
Price €1.80
GF Value €4.29
! 6 Warning Signs
View Full Analysis

What is Natural Alternatives International FFO per Share?

FFO per Share only applies to REITs.

FRA:NA2
48GF Score
Natural Alternatives International Inc FRA:NA2
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Natural Alternatives International (FRA:NA2) Overvalued in 2026?

Based on GuruFocus' analysis, Natural Alternatives International stock appears to be undervalued. The current stock price of €1.80 is trading 58% below its estimated GF Value™ of €4.29.

Key valuation signals for FRA:NA2:

  • FFO per Share:
  • GF Value™: €4.29 vs. price of €1.80 (58% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the FRA:NA2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natural Alternatives International Business Description

Other Exchanges NAII:USA
Address 1535 Faraday Avenue, Carlsbad, CA, USA, 92008
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
48GF Score

Get the complete analysis for FRA:NA2

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.80
Price
€4.29
GF Value